2024 was a breakthrough year for #GenitourinaryCancer! 🚀
@danafarber.bsky.social made huge strides-from new prostate & kidney cancer therapies to blood tests that personalize treatment. Awesome to see research turning into real hope for patients like my cousin! 👏🏽🔬 #CancerResearch #Innovation
@danafarber.bsky.social made huge strides-from new prostate & kidney cancer therapies to blood tests that personalize treatment. Awesome to see research turning into real hope for patients like my cousin! 👏🏽🔬 #CancerResearch #Innovation
“Our focused efforts are yielding results that are helping patients today and guiding our research towards more advances in the future,” says @drchoueiri.bsky.social. Learn about the research advancements our Lank Center for Genitourinary Oncology has made this past year.
A Year of Advances in Genitourinary Cancer
Published: February 6, 2025Written by: Beth DoughertyMedically Reviewed By: Atish Choudhury, MD, PhD, Toni Choueiri, MD, and Mark Pomerantz, MDDana-Farber’s genitourinary cancer team is devoted to res...
bit.ly
May 10, 2025 at 1:41 PM
2024 was a breakthrough year for #GenitourinaryCancer! 🚀
@danafarber.bsky.social made huge strides-from new prostate & kidney cancer therapies to blood tests that personalize treatment. Awesome to see research turning into real hope for patients like my cousin! 👏🏽🔬 #CancerResearch #Innovation
@danafarber.bsky.social made huge strides-from new prostate & kidney cancer therapies to blood tests that personalize treatment. Awesome to see research turning into real hope for patients like my cousin! 👏🏽🔬 #CancerResearch #Innovation
💥Tumori Journal is really proud that three internationally renowned oncologists have joined the #EditorialBoard!
Meet them visiting the link tumorijournal.org/about-us/#ed...
#Breastcancer #Genitourinarycancer #CanSky #OncSky
Meet them visiting the link tumorijournal.org/about-us/#ed...
#Breastcancer #Genitourinarycancer #CanSky #OncSky
April 11, 2025 at 2:34 PM
💥Tumori Journal is really proud that three internationally renowned oncologists have joined the #EditorialBoard!
Meet them visiting the link tumorijournal.org/about-us/#ed...
#Breastcancer #Genitourinarycancer #CanSky #OncSky
Meet them visiting the link tumorijournal.org/about-us/#ed...
#Breastcancer #Genitourinarycancer #CanSky #OncSky
We’re live in San Francisco covering the latest in #genitourinarycancer at #GU25 🌉
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
February 13, 2025 at 5:17 PM
We’re live in San Francisco covering the latest in #genitourinarycancer at #GU25 🌉
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
We’re looking forward to seeing our colleagues in #genitourinarycancer at the @ascocancer.bsky.social Genitourinary Cancers Symposium this week. Watch for poster information for our @yalecancer.bsky.social presenters! #GU25
February 13, 2025 at 4:34 PM
We’re looking forward to seeing our colleagues in #genitourinarycancer at the @ascocancer.bsky.social Genitourinary Cancers Symposium this week. Watch for poster information for our @yalecancer.bsky.social presenters! #GU25